# FDA Inspection 1266574 - PCI Pharma Services Canada, Inc. - February 28, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/pci-pharma-services-canada-inc/db327164-ec35-4180-91f4-00ce33bff91e
Source feed: FDA_Inspections

> FDA Inspection 1266574 for PCI Pharma Services Canada, Inc. on February 28, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266574
- Company Name: PCI Pharma Services Canada, Inc.
- Inspection Date: 2025-02-28
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1266574 - 2025-02-28](https://www.globalkeysolutions.net/records/fda_inspections/pci-pharma-services-canada-inc/8a862647-ba3e-482b-a87a-b3f5dec6ba4a)
- [FDA Inspection 1091465 - 2019-04-17](https://www.globalkeysolutions.net/records/fda_inspections/pci-pharma-services-canada-inc/66ca5be0-c192-4d38-9859-9a12a3f1066f)
- [FDA Inspection 852213 - 2013-09-25](https://www.globalkeysolutions.net/records/fda_inspections/pci-pharma-services-canada-inc/8c20b840-f7aa-455b-aa85-0dabe73a2b73)

Company: https://www.globalkeysolutions.net/companies/pci-pharma-services-canada-inc/0122dddb-ebe8-44f4-bba1-9427041d01c3

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c